Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells

Published:2019-01-01 Issue:1 Volume:26 Page:281-289
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Zhou Jianwen¹²,Sun Mingshuang³,Jin Shanshan⁴,Fan Li⁵,Zhu Wenquan²,Sui Xiaoyu²,Cao Lixin⁶,Yang Chunrong¹,Han Cuiyan²

Affiliation:

1. School of Pharmacy, Jiamusi University, Jiamusi, China;

2. School of Pharmacy, Qiqihar Medical University, Qiqihar, China;

3. School of Pharmacy, Taishan Medical University, Taian, China;

4. Department of Pharmaceutical Preparations, Beijing Dezhong Wanquan Medicine Technology Co., Ltd, Beijing, China;

5. Research Institute of Medicine & Pharmacy, Qiqihar Medical University, Qiqihar, China;

6. Department of Orthopedics, the First Affiliated Hospital of Qiqihar Medical University, Qiqihar, China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2019.1580799

Reference33 articles.

1. Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1

2. Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition

3. Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery

4. Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

5. Paclitaxel (Taxol) and Docetaxel (Taxotere): active chemotherapeutic agents in lung cancer

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concomitant Delivery of Pirarubicin and Salinomycin Synergistically Enhanced the Efficacy of Cancer Therapy and Reduced the Risk of Cancer Relapse;AAPS PharmSciTech;2024-09-07

2. Lipid Nanoparticles in Lung Cancer Therapy;Pharmaceutics;2024-05-10

3. Specific Application of Lipid-Based Nanoparticular Drug Delivery Systems for Cancer Therapy;Handbook of Cancer and Immunology;2023-11-13

4. Biguanide-anchored albumin-based nanoplatform inhibits epithelial-mesenchymal transition and reduces the stemness phenotype for metastatic cancer therapy;Acta Biomaterialia;2023-11

5. Oxidative stress induction by narasin augments doxorubicin’s efficacy in osteosarcoma;BMC Pharmacology and Toxicology;2023-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3